These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30506201)

  • 1. Prenatal Diagnosis of Cystic Fibrosis.
    Fedick AM; Zhang J; Edelmann L; Kornreich R
    Methods Mol Biol; 2019; 1885():221-231. PubMed ID: 30506201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
    Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
    Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal and newborn screening for CFTR mutations: the difficulties of prediction.
    Schwarz MJ
    Clin Biochem; 2011 May; 44(7):485-486. PubMed ID: 22036338
    [No Abstract]   [Full Text] [Related]  

  • 4. An update on cystic fibrosis screening.
    Goetzinger KR; Cahill AG
    Clin Lab Med; 2010 Sep; 30(3):533-43. PubMed ID: 20638569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From gene to disease; from defective chloride ion transport to cystic fibrosis].
    Scheffer H; van den Ouweland AM; Veeze HJ
    Ned Tijdschr Geneeskd; 2001 Apr; 145(14):686-7. PubMed ID: 11530706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders.
    Moskowitz SM; Chmiel JF; Sternen DL; Cheng E; Gibson RL; Marshall SG; Cutting GR
    Genet Med; 2008 Dec; 10(12):851-68. PubMed ID: 19092437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier screening for cystic fibrosis.
    Dungan JS
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):47-59, Table of Contents. PubMed ID: 20494257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characterisation of circulating fetal cells allows non-invasive prenatal diagnosis of cystic fibrosis.
    Saker A; Benachi A; Bonnefont JP; Munnich A; Dumez Y; Lacour B; Paterlini-Brechot P
    Prenat Diagn; 2006 Oct; 26(10):906-16. PubMed ID: 16832834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for quality improvement in genetic testing for cystic fibrosis. European Concerted Action on Cystic Fibrosis.
    Dequeker E; Cuppens H; Dodge J; Estivill X; Goossens M; Pignatti PF; Scheffer H; Schwartz M; Schwarz M; Tümmler B; Cassiman JJ
    Eur J Hum Genet; 2000 Sep; 8 Suppl 2():S2-24. PubMed ID: 11108532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials.
    Wilschanski M; Dupuis A; Ellis L; Jarvi K; Zielenski J; Tullis E; Martin S; Corey M; Tsui LC; Durie P
    Am J Respir Crit Care Med; 2006 Oct; 174(7):787-94. PubMed ID: 16840743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A continuing role for sweat testing in an era of newborn screening for cystic fibrosis.
    Kirk JM
    Clin Biochem; 2011 May; 44(7):487-488. PubMed ID: 22036339
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening practices for mutations in the CFTR gene ABCC7.
    Girodon-Boulandet E; Cazeneuve C; Goossens M
    Hum Mutat; 2000; 15(2):135-49. PubMed ID: 10649490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
    Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis in Korean children:a case report identified by a quantitative pilocarpine iontophoresis sweat test and genetic analysis.
    Ahn KM; Park HY; Lee JH; Lee MG; Kim JH; Kang IJ; Lee SI
    J Korean Med Sci; 2005 Feb; 20(1):153-7. PubMed ID: 15716623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N1303K and IVS8-5T, clinical presentation within a family with atypical cystic fibrosis.
    Van Hoorenbeeck K; Storm K; van den Ende J; Biervliet M; Desager KN
    J Cyst Fibros; 2007 May; 6(3):220-2. PubMed ID: 17127107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The D1152H cystic fibrosis mutation in prenatal carrier screening, patients and prenatal diagnosis.
    Peleg L; Karpati M; Bronstein S; Berkenstadt M; Frydman M; Yonath H; Pras E
    J Med Screen; 2011; 18(4):169-72. PubMed ID: 22156145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
    Schwartz M
    Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic Fibrosis: A Review of Associated Phenotypes, Use of Molecular Diagnostic Approaches, Genetic Characteristics, Progress, and Dilemmas.
    Brennan ML; Schrijver I
    J Mol Diagn; 2016 Jan; 18(1):3-14. PubMed ID: 26631874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cystic fibrosis--the most frequent life-shortening autosomal recessive disease].
    Wieser R
    Wien Med Wochenschr; 2005 Jun; 155(11-12):268-72. PubMed ID: 16035387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.